In an interview with Bret Weinstein Ph.D., Dr. Pierre Kory, president and chief medical officer of the Frontline COVID-19 Critical Care Alliance discussed the importance of early treatment of COVID-19 and the shameful censoring of information about ivermectin.

The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It’s free.

Story at-a-glance:

• Data clearly show ivermectin can prevent COVID-19 and when used early can keep patients from progressing to the hyper-inflammatory phase of the disease. It can even help critically ill patients recover.
• Ivermectin has a long history of use as an antiparasitic, but its antiviral properties have been under investigation since 2012.
• Studies have shown ivermectin inhibits replication of SARS-CoV-2 and seasonal influenza viruses, inhibits inflammation through several pathways, lowers viral load, protects against organ damage, prevents transmission of SARS-CoV-2 when taken before or after exposure, speeds recovery and lowers risk of hospitalization and death in COVID-19 patients.
• Doctors have been told not to use ivermectin as large controlled trials are still lacking. However, once you can see from clinical evidence that something is working, then conducting controlled trials becomes unethical, as you know you’re condemning the control group to poor outcomes or death. In fact, this is the exact argument vaccine makers now use to justify the elimination of control groups and giving everyone the vaccine.
• The Frontline COVID-19 Critical Care Alliance recommends widespread use of ivermectin for all stages of COVID-19, including prevention.